HCPCS Level IIdrugActive
J7171
Inj, adzynma, 10 iu
BETOS: O1E
Effective: 2024-07-01
Referenced in 1 policies
Description
Injection, adamts13, recombinant-krhn, 10 iu
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Adzynma
Manufacturer
Takeda Pharmaceuticals America, Inc.
HCPCS Dosage
10 UNITS
Billing Units
1.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.